Catarina Costa

POSITION: Post-doctoral researcher

RESEARCH THEME: Fungal Pathogenesis and Drug Resistance


Research Topics

  • Mechanisms of antifungal drug resistance in the human pathogen Candida glabrata
  • Microbial physiology and molecular biology
  • Chemogenomics and expression proteomics

Selected Publications

Costa, C., Ribeiro, J., Miranda, I.M., Silva-Dias, A.I., Cavalheiro, M., Costa-de-Oliveira, S., Rodrigues, A.G., Teixeira, M.C., “Clotrimazole drug resistance in Candida glabrata clinical isolates correlates with increased expression of the drug:H+ antiporters CgAqr1, CgTpo1_1, CgTpo3 and CgQdr2", Frontiers in Microbiology, 7:256, 2016.

Costa, C., Ponte, A., Pais, P., Santos, R., Cavalheiro, M., Takashi, Y., Chibana, H., Teixeira, M.C., “New mechanisms of flucytosine resistance in C. glabrata unveiled by a chemogenomics analysis in S. cerevisiae", PLoS ONE, 10(8):e0135110, 2015.

Costa, C., Nunes, J., Henriques, A., Mira, N.P., Nakayama, H., Chibana, H., Teixeira, M.C., The Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis, Journal of Antimicrobial Chemotherapy, 69:1767-76, 2014.

Costa, C., Pires, C., Cabrito, T.R., Renaudin, A., Ohno, M., Chibana, H., Sá-Correia, I., Teixeira, M.C., “Candida glabrata drug:H+ antiporter CgQdr2 (ORF CAGL0G08624g) confers imidazole drug resistance, being activated by the CgPdr1 transcription factor", Antimicrobial Agents and Chemotherapy, 57(7):3159-67, 2013.

Costa, C., Henriques, A.S., Pires, C., Nunes, J., Ohno, M., Chibana, H., Sá-Correia, I., Teixeira, M.C., The dual role of Candida glabrata Drug:H+ Antiporter CgAqr1 (ORF CAGL0J09944g) in antifungal drug and acetic acid resistance, Frontiers in Microbiology, 4:170, 2013. 

Alternative web pages